Validity of Somatosensori Remediation for Postural Control in the Treatment of Ehlers-Danlos Syndrome Hypermobility Type (hEDS)

NCT ID: NCT04020107

Last Updated: 2023-02-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-29

Study Completion Date

2022-11-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the absence of a medical consensus, the current management of Ehlers-Danlos Syndrome hypermobility type (hEDS) remains very speculative That's why investigators want in this study to demonstrate the beneficial contribution of an innovative therapeutic strategy combining reprogramming and substitution somatosensory. This therapy is based primarily on the somesthetic substitution provided by compression garments(VC). Indeed, the VC port associated with stimulation of the somesthetic system via a specific program of physiotherapy (e.e. centered on body awareness through movement) could potentiate the effectiveness of care, and therefore enhance its long-term beneficial effect. The patient could thus regain his mobility, his functional independence, and thus considerably increase its quality of life. Thereafter, the practice of an adapted physical activity (APA), by the sensory stimulation induced and its playful nature, will allow patients to preserve and sustain the benefits of taking load previously carried out. Validation of this therapeutic approach would offer an effective solution may subsequently be proposed to the entire medical profession as reference support in the treatment of the hEDS.

This study plans to include, over a period of two years, 40 patients with hypermobile Ehlers-Danlos syndrome and 40 healthy volunteers controls. Patients will be followed for a period of one year divided into 3 periods of 4 months, between which they will be evaluated in order to quantify the impact of the intervention performed at each stage of the protocol.

Each patient will benefit successively: from a classic care, over a period of 2 to 4 months, then will be treated with compressive garments or with low compressive garment during the next 4 months in association with proprioceptive physical therapy. Finally, the 4 last months, patient will participate in an APA with both dance sessions strengthening the body diagram and stretching sessions.

The aim of this work is therefore to evaluate the effect of a treatment specifically oriented towards somatosensory remediation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ehlers-Danlos Syndrome Hypermobility Type (hEDS)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Compressive garment associated with physical therapy

Group Type ACTIVE_COMPARATOR

Compressive garment and Somatosensori Remediation

Intervention Type OTHER

Each patient will benefit successively: from a classic care, over a period of 2 to 4 months, then will be treated with compressive or low compressive garments associated with specific proprioceptive physiotherapy program during the next 4 months. Finally, the 4 last months, patient will made adapted physical activity with both dance sessions strengthening the body diagram and stretching sessions

Low compressive garment associated with physical therapy

Group Type PLACEBO_COMPARATOR

Compressive garment and Somatosensori Remediation

Intervention Type OTHER

Each patient will benefit successively: from a classic care, over a period of 2 to 4 months, then will be treated with compressive or low compressive garments associated with specific proprioceptive physiotherapy program during the next 4 months. Finally, the 4 last months, patient will made adapted physical activity with both dance sessions strengthening the body diagram and stretching sessions

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Compressive garment and Somatosensori Remediation

Each patient will benefit successively: from a classic care, over a period of 2 to 4 months, then will be treated with compressive or low compressive garments associated with specific proprioceptive physiotherapy program during the next 4 months. Finally, the 4 last months, patient will made adapted physical activity with both dance sessions strengthening the body diagram and stretching sessions

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

For EDS patients :

* Subjects aged 18 to 40,
* SEDh patients newly diagnosed for less than 2 years according to international criteria of 2017,
* Having a Body Mass Index (BMI) of less than 30,
* Affiliated to a social security scheme,
* Having read the information document and given in writing their free and informed consent to participate in the study.

For healthy volunteers :

* Subjects aged 18 to 40,
* Having a Body Mass Index (BMI) of less than 30,
* Having a Beigthon score \<5 (no joint hypermobility),
* Having normal muscle strength,
* Affiliated to a social security scheme,
* Having read the information document and given in writing their free and informed consent to participate in the study.

Exclusion Criteria

For EDS patients :

* Subjects under 18,
* Proprioceptive physiotherapy (Huber 360 platform type, LPG) in progress or already performed,
* previous treatment of hEDS capable of limiting the effects of rehabilitation (e.g. orthodontics, orthoptics),
* Diagnosis of other connective tissue abnormalities,
* Earlier prescription of compression garments,
* Pregnant or lactating women,
* Lack of effective contraception during the study period for women
* Person under tutorship or curatorship, or deprived of liberty by judicial or administrative decision,
* Mental or physical impossibility to agree to participate in the study,
* Known allergy to one of the components of compression garments,
* Disabling motor impairment, or limiting the performance of motor and psychomotor tests.
* Simultaneous participation in another clinical study.

For healthy volunteers :

* Subjects under 18,
* History of vascular, neurological, musculoskeletal or vestibular disorders,
* Having orthoptic, orthopedic or orthodontic disorders,
* Previous history or progressive disease of vascular, ophthalmological, neurological, musculoskeletal condition, or vestibular condition
* Pregnant or lactating women,
* Person under tutorship or curatorship, or deprived of liberty by judicial or administrative decision,
* Mental or physical impossibility to agree to participate in the study,
* Simultaneous participation in another clinical study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Caen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Caen Univerity Hospital

Caen, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-2012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.